摘要
目的:评估我院围手术期患者雾化吸入的给药情况,为临床合理用药提供参考。方法:通过美康合理用药工作站调取电子病历结合手工检索,回顾性调研我院外科病区部分出院患者,评估围手术期雾化吸入给药的相关指标。结果:186例手术患者围手术期应用雾化吸入给药各病区比率63.79%～100.00%;雾化吸入应用最多的药物是盐酸氨溴索注射液、0.9%氯化钠注射液以及注射用硫酸依替米星;单次给药容量符合要求的占56.59%;单一用药和二联用药所占比例分别为31.71%和54.15%。结论:我院围手术期雾化吸入给药基本合理,但仍存在单次给药容量过大、不合理药物联用等现象。临床医师应与药师密切配合,综合评价,优化雾化吸入给药方案。
Objective： To assess the ration of atomization inhalation medicine which was given to the patients in the perioperative period to provide possible reference for the application of medicine in operations. Method： From the clinical pharmacy workstation combined with manual retrieval method, a research was done among some patients who had once received treatments in the four surgical wards of our hospital in order to assess the related index of the ration of atomization inhalation medicine given to the patients in the perioperative period. Result： Among the 186 patients, the proportion of the used atomization inhalation medicine ration ranged from 63.79% to 100.00%. The medicines used in the largest amount were Ambroxol Hydrochloride Injection, Sodium Chloride Injection and Etimicin Sulfate for Injection. The qualified proportion of the ration of the medicine applied to patients each single time was 56.59%. The proportions of single medicine and double medicine were 31.71% and 54.15% , respectively. Conclusion： The atomization inhalation medicine applied to the patients is basically rational in our hospital, but the overdose use of medicine in a single time and the irrational combined use of different medicines still exist. The clinicians and pharmacists need a close cooperation with each other, and analyze the process comprehensively in order to improve the atomization inhalation medicine＇s application.
出处
《药物流行病学杂志》
CAS
2009年第5期367-369,共3页
Chinese Journal of Pharmacoepidemiology
关键词
围手术期
雾化吸入
联合用药
评价
Perioperative Period
Atomization inhalation
Drug combination
Evaluation
